Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technologyThe roles of mesenchymal stem cells in tumor inflammatory microenvironmentIntraperitoneally infused human mesenchymal stem cells form aggregates with mouse immune cells and attach to peritoneal organs.Concise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular FractionMicroarray based analysis of gene regulation by mesenchymal stem cells in breast cancerIFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.Unique characteristics of human mesenchymal stromal/progenitor cells pre-activated in 3-dimensional cultures under different conditions.Bone Marrow-derived Cell Therapy for Oral Mucosal Repair after IrradiationHuman bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasionPotential of Mesenchymal Stem Cell based application in CancerOxygen Tension Regulates Human Mesenchymal Stem Cell Paracrine Functions.Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.Overexpression of Glutamate Decarboxylase in Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties and Increases GABA and Nitric Oxide Levels.Acute promyelocytic leukemia following autologous bone marrow-derived mesenchymal stem cell transplantation for traumatic brain injury: A case report.Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancerMesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection statusA20 plays a critical role in the immunoregulatory function of mesenchymal stem cellsActivation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway.Human-derived normal mesenchymal stem/stromal cells in anticancer therapies.Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms.Effect of Transplantation of Bone Marrow Derived Mesenchymal Stem Cells and Platelets Rich Plasma on Experimental Model of Radiation Induced Oral Mucosal Injury in Albino Rats.Enhancing the efficacy of mesenchymal stem cell therapy.Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors.Mesenchymal stem cell priming: fine-tuning adhesion and function.Are clinical trials with mesenchymal stem/progenitor cells too far ahead of the science? Lessons from experimental hematologyGene-directed enzyme prodrug therapy.Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?Mesenchymal Stem Cells Relevance in Multicellular Bioengineered 3D In vitro Tumor Models.Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth.Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.Mesenchymal stromal cells with enhanced therapeutic properties.Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.The taxonomy of brain cancer stem cells: what's in a name?
P2860
Q26746104-0CC9111D-C3C1-4FC5-93F1-C23CB38193B4Q26798274-B1A44C86-8B53-4E40-A8AD-DDEBC24C0B88Q26821929-0B96C550-062C-4ABE-911B-D9F34F04FF7EQ26823759-331DA7B1-3A91-49F8-839D-4C020CB3C90FQ27322349-8205DC86-1B33-4A98-82C0-CB40467D4D7EQ33553011-7C393A5F-7B19-4555-B676-0146E199D7A4Q33599142-33918EB3-9AB0-4D55-A0D1-5D79AA208EDDQ33757703-ACDC1DC8-4819-4017-8826-57FD591BE35AQ34307885-BD43946E-2539-4618-81A2-EC6F38A38B03Q34950295-2DCA8024-F295-4FCE-86E8-3B8D0CB3464AQ35035492-1D73A9E3-D268-4A08-AEF7-C11922AEDEB9Q35540034-67A752F5-5FFA-4908-B464-420267C6B1E5Q35777498-66A51C12-580A-4104-9544-9B0667AD2008Q35862799-9B57810F-51E5-4727-9034-01C1FA98E602Q36142956-0FE1B6F9-1DDE-483B-8569-CEF6FEE4C9F8Q36334567-47B91967-084C-4741-B496-ABD6CAF59097Q36587186-F35B4F9E-C57E-481A-B72C-9FBD3E2C0C24Q36651828-8F64BF21-B359-4184-B66C-3790A6D6BFB4Q36661456-56D3ADAE-DDBF-4A07-9BFA-AB06A65089BBQ37117174-0A38193C-20A9-41C9-B11B-FA29618ED497Q37190486-25127306-949B-4F90-96A0-011D00389D04Q37326277-B37106D6-B997-41D3-A56C-B19E5D8A15F0Q37372102-248DE1D1-4BAA-4A97-9775-FB01E0839281Q37604317-6A697E30-AFCB-4CE5-9CCD-47721087A1C7Q37678939-13F63D7B-B18A-4B45-8E67-57072E11587BQ37694235-0C8D7450-A0BF-45CF-80F4-1F2BB91F2EE4Q37723500-7FE1B0A2-DAB9-40FD-B833-D9AADDEC1956Q38139850-BDD0FF87-D2BC-4153-B7AC-A7354453AFE0Q38206110-A7162BE7-9820-4CEA-8F18-7B5D4D85FEF9Q38237590-96784450-48E0-4DEF-ACDB-C94F3C60A229Q38262019-D6E2C0A0-A156-4FBC-AEDA-BD1796AC9735Q38341972-70275B2E-806D-486A-9F16-5E0705BCC712Q38638108-60E2F400-7C72-4C13-BEBD-9CA10452E5C7Q38657264-BEB058DB-195C-4F32-80FF-346D684ABA33Q38761193-B868237B-DC61-4AE4-AF83-0B89E83AFD9BQ38806320-6EB743E8-104E-41C7-A306-DC2B7B34226FQ39012031-EB351707-6BB5-4410-8EEF-AEFC7EC1EC95Q39045625-FA2845B6-52CC-4298-9EB4-F0A10CFF54F8Q39049644-0D9C0835-41CC-487A-9F7A-E8EF4711D45CQ39056846-01870435-9F4D-4C9D-8FF3-B20CBD4F590C
P2860
Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Mesenchymal stem cell 1 (MSC1) ...... s tumor growth and metastasis.
@ast
Mesenchymal stem cell 1 (MSC1) ...... s tumor growth and metastasis.
@en
Mesenchymal stem cell 1
@nl
type
label
Mesenchymal stem cell 1 (MSC1) ...... s tumor growth and metastasis.
@ast
Mesenchymal stem cell 1 (MSC1) ...... s tumor growth and metastasis.
@en
Mesenchymal stem cell 1
@nl
prefLabel
Mesenchymal stem cell 1 (MSC1) ...... s tumor growth and metastasis.
@ast
Mesenchymal stem cell 1 (MSC1) ...... s tumor growth and metastasis.
@en
Mesenchymal stem cell 1
@nl
P2093
P2860
P1433
P1476
Mesenchymal stem cell 1 (MSC1) ...... s tumor growth and metastasis.
@en
P2093
Aline M Betancourt
Ruth S Waterman
Sarah L Henkle
P2860
P304
P356
10.1371/JOURNAL.PONE.0045590
P407
P577
2012-09-20T00:00:00Z